Cerebral Venous Sinus Thrombosis as a Rare Complication of Systemic Lupus Erythematosus: Subgroup Analysis of the VENOST Study

Basit Öğe Kaydı
dc.contributor.authorDuman, Taskin
dc.contributor.authorDemirci, Seden
dc.contributor.authorUluduz, Derya
dc.contributor.authorKozak, Hasan Huseyin
dc.contributor.authorDemir, Serkan
dc.contributor.authorMisirli, Cemile Handan
dc.contributor.authorKucukoglu, Hayriye
dc.date.accessioned2024-04-24T16:15:23Z
dc.date.available2024-04-24T16:15:23Z
dc.date.issued2019
dc.departmentDicle Üniversitesien_US
dc.description.abstractAim: Systemic lupus erythematosus (SLE) is an unusual risk factor for cerebral venous sinus thrombosis (CVST). As few CVST patients with SLE have been reported, little is known regarding its frequency as an underlying etiology, clinical characteristics, or long-term outcome. We evaluated a large cohort of CVST patients with SLE in a multicenter study of cerebral venous thrombosis, the VENOST study, and their clinical characteristics. Material and Method: Among the 1144 CVST patients in the VENOST cohort, patients diagnosed with SLE were studied. Their demographic and clinical characteristics, etiological risk factors, venous involvement status, and outcomes were recorded. Results: In total, 15 (1.31%) of 1144 CVST patients had SLE. The mean age of these patients was 39.9 +/- 12.1 years and 13 (86.7%) were female. Presenting symptoms included headache (73.3%), visual field defects (40.0%), and altered consciousness (26.7%). The main sinuses involved were the transverse (60.0%), sagittal (40.0%), and sigmoid (20.0%) sinuses. Parenchymal involvement was not seen in 73.3% of the patients. On the modified Rankin scale, 92.9% of the patients scored 0-1 at the 1-month follow-up and 90.9% scored 0-1 at the 1-year follow-up. Conclusions: SLE was found in 1.31% of the CVST patients, most frequently in young women. Headache was the most common symptom and the CVST onset was chronic in the majority of cases. The patient outcomes were favorable. CVST should be suspected in SLE patients, even in those with isolated chronic headache symptoms with or without other neurological findings.en_US
dc.identifier.doi10.1016/j.jstrokecerebrovasdis.2019.104372
dc.identifier.issn1052-3057
dc.identifier.issn1532-8511
dc.identifier.issue12en_US
dc.identifier.pmid31562041
dc.identifier.scopus2-s2.0-85072605600
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104372
dc.identifier.urihttps://hdl.handle.net/11468/15780
dc.identifier.volume28en_US
dc.identifier.wosWOS:000498868800011
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofJournal of Stroke & Cerebrovascular Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSystemic Lupus Erythematosusen_US
dc.subjectCerebral Venous Sinus Thrombosisen_US
dc.subjectHeadacheen_US
dc.subjectNeurological Symptomsen_US
dc.titleCerebral Venous Sinus Thrombosis as a Rare Complication of Systemic Lupus Erythematosus: Subgroup Analysis of the VENOST Studyen_US
dc.titleCerebral Venous Sinus Thrombosis as a Rare Complication of Systemic Lupus Erythematosus: Subgroup Analysis of the VENOST Study
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu